![glp-1 기전 하남시내과, GLP-1과 GIP, 글루카곤 조절 : 듀얼 인크레틴의 넷 이펙트 : 네이버 블로그 후생신보] 대한당뇨병학회 및 심평원 초청](https://mblogthumb-phinf.pstatic.net/MjAyNTA4MTFfMTQ2/MDAxNzU0OTE1NDQyODE1.FO6moNuvMuMCRxQlB6nxEYoyvsWnDS1zknvpEQ2oCgkg.GTffFWS5aG6AeVDO933fJvf9UW2_EWWrrESjqgXyJR8g.JPEG/SE-d9fa5012-5700-49b4-b509-0e815fe81efe.jpg?type=w800)
glp-1 기전 하남시내과, GLP-1과 GIP, 글루카곤 조절 : 듀얼 인크레틴의 넷 이펙트 : 네이버 블로그 후생신보] 대한당뇨병학회 및 심평원 초청
Description
303:1410-1418 [PubMed: 20388897] 31
![glp-1 , GLP-1 GIP, : : ]](http://newsx.ecn.cdn.infralab.net/www.whosaeng.com/imgdata/whosaeng_com/201402/2014022723301214.jpg)
Obesity in Europe 1993
In summary, it is time to emerge from the dark ages and to consider initiation of therapy in type 2 diabetes patients with a GLP-1 plus an SGLT2, starting with the GLP-1 receptor agonist as per Apperloo and colleagues and Dave and colleagues
![glp-1 , GLP-1 GIP, : : ]](http://dept.snuh.org/upload/editor/images/000034/20250905124334812_YPREOG8R.png)
The benefits include appetite suppression and better blood sugar control
![glp-1 , GLP-1 GIP, : : ]](https://pds.dailypharm.com/news_image/202501/319189_p.jpg)
S5A and I), -SMA (Fig
![glp-1 , GLP-1 GIP, : : ]](https://img1.daumcdn.net/thumb/R800x0/?scode=mtistory2&fname=https%3A%2F%2Fblog.kakaocdn.net%2Fdna%2FcrXsVy%2FbtsGR1i9QNf%2FAAAAAAAAAAAAAAAAAAAAAB_JcsHgdS3PkGybTDkPOkVkXnoJknSwJnjF7mf8PSny%2Fimg.png%3Fcredential%3DyqXZFxpELC7KVnFOS48ylbz2pIh7yKj8%26expires%3D1785509999%26allow_ip%3D%26allow_referer%3D%26signature%3DVWmEbQ1anvf%252BWIebIFIdmDszFxE%253D)
Individuals with strong genetic loading for obesity may respond poorly to caloric restriction alone, regardless of app engagement
![glp-1 , GLP-1 GIP, : : ]](https://cdn.monews.co.kr/news/photo/202104/303123_72783_3032.jpg)
